These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8651950)
41. Activation of central GABA Sallam MY; El-Gowilly SM; Abdel-Galil AA; El-Mas MM Fundam Clin Pharmacol; 2018 Oct; 32(5):485-498. PubMed ID: 29667225 [TBL] [Abstract][Full Text] [Related]
42. The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer. Rushing DA; Raber SR; Rodvold KA; Piscitelli SC; Plank GS; Tewksbury DA Cancer; 1994 Aug; 74(3):834-41. PubMed ID: 8039111 [TBL] [Abstract][Full Text] [Related]
43. Steady-state pharmacokinetics of mycophenolic acid in renal transplant patients: exploratory analysis of the effects of cyclosporine, recipients' and donors' ABCC2 gene variants, and their interactions. Božina N; Lalić Z; Nađ-Škegro S; Borić-Bilušić A; Božina T; Kaštelan Ž; Trkulja V Eur J Clin Pharmacol; 2017 Sep; 73(9):1129-1140. PubMed ID: 28624888 [TBL] [Abstract][Full Text] [Related]
44. Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study. Wu X; Li Q; Xin H; Yu A; Zhong M Eur J Clin Pharmacol; 2005 Sep; 61(8):567-72. PubMed ID: 16133554 [TBL] [Abstract][Full Text] [Related]
45. Polymeric micelles for the solubilization and delivery of cyclosporine A: pharmacokinetics and biodistribution. Aliabadi HM; Brocks DR; Lavasanifar A Biomaterials; 2005 Dec; 26(35):7251-9. PubMed ID: 16005061 [TBL] [Abstract][Full Text] [Related]
46. Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension. Zhang W; Victor RG Am J Hypertens; 2000 Sep; 13(9):999-1004. PubMed ID: 10981550 [TBL] [Abstract][Full Text] [Related]
47. Effect of anti-transforming growth factor-beta antibodies in cyclosporine-induced renal dysfunction. Islam M; Burke JF; McGowan TA; Zhu Y; Dunn SR; McCue P; Kanalas J; Sharma K Kidney Int; 2001 Feb; 59(2):498-506. PubMed ID: 11168932 [TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetics and tissue distribution of liposomal etoposide in rats. Sistla A; Smith DJ; Kobrinsky NL; Kumar K Drug Deliv; 2009 Nov; 16(8):423-9. PubMed ID: 19839786 [TBL] [Abstract][Full Text] [Related]
49. Pharmacokinetics and distribution of tris(maltolato)aluminum(III) into the central nervous system. Allen DD; Orvig C; Yokel RA Neurotoxicology; 1994; 15(2):371-8. PubMed ID: 7991226 [TBL] [Abstract][Full Text] [Related]
50. Distribution of the novel antifolate pemetrexed to the brain. Dai H; Chen Y; Elmquist WF J Pharmacol Exp Ther; 2005 Oct; 315(1):222-9. PubMed ID: 15987831 [TBL] [Abstract][Full Text] [Related]
51. Effect of a P-glycoprotein inhibitor, Cyclosporin A, on the disposition in rodent brain and blood of the 5-HT1A receptor radioligand, [11C](R)-(-)-RWAY. Liow JS; Lu S; McCarron JA; Hong J; Musachio JL; Pike VW; Innis RB; Zoghbi SS Synapse; 2007 Feb; 61(2):96-105. PubMed ID: 17117422 [TBL] [Abstract][Full Text] [Related]
52. Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates. Warren KE; Patel MC; McCully CM; Montuenga LM; Balis FM Cancer Chemother Pharmacol; 2000; 45(3):207-12. PubMed ID: 10663638 [TBL] [Abstract][Full Text] [Related]
53. Induction of endothelin in rat kidney after cyclosporine A treatment. Rezzani R; Rodella L; Bianchi R Acta Histochem; 2001 Oct; 103(4):423-31. PubMed ID: 11700947 [TBL] [Abstract][Full Text] [Related]
54. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats]. Liu XL; Tang J; Song J; He J; Xu P; Peng WX Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838 [TBL] [Abstract][Full Text] [Related]
55. Fluctuations in vancomycin CNS tissue concentrations following intermittent and continuous infusions in the rat. Luer MS; Neill KK; Gurley BJ; Shannon ML; Killian AD; Rodvold KA Neurol Res; 2004 Apr; 26(3):312-5. PubMed ID: 15142325 [TBL] [Abstract][Full Text] [Related]
56. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat. Nielsen FT; Ottosen P; Starklint H; Dieperink H Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269 [TBL] [Abstract][Full Text] [Related]
57. In vivo brain microdialysis as a tool in studies of neuroprotective effects of cyclosporin A in acute excitotoxicity. Ziemińska E; Matyja E; Nałecz M; Salińska E; Ziembowicz A; Łazarewicz JW Acta Pol Pharm; 2000 Nov; 57 Suppl():129-33. PubMed ID: 11293243 [TBL] [Abstract][Full Text] [Related]
58. Analysis of the interactions of SDZ PSC 833 ([3'-keto-Bmt1]-Val2]-Cyclosporine), a multidrug resistance modulator, with P-glycoprotein. Archinal-Mattheis A; Rzepka RW; Watanabe T; Kokubu N; Itoh Y; Combates NJ; Bair KW; Cohen D Oncol Res; 1995; 7(12):603-10. PubMed ID: 8704277 [TBL] [Abstract][Full Text] [Related]
60. Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells. Waiser J; Dell K; Böhler T; Dogu E; Gaedeke J; Budde K; Neumayer HH Nephrol Dial Transplant; 2002 Sep; 17(9):1568-77. PubMed ID: 12198207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]